Zydus Lifesciences Acquires 50% Stake in Joint Venture With Sunshine Healthcare Lanka
New Delhi: Zydus Lifesciences Ltd on Thursday said it has completed the transaction to subscribe to a 50 per cent stake in Zydus Sunshine Lifesciences Pvt Ltd, making it a 50:50 joint venture alongside Sunshine Healthcare Lanka Limited.
The transaction involving the subscription of shares and formation of the joint venture was completed on November 11, 2026, according to a regulatory filing.
The company noted that there was a delay in sending the intimation due to office holidays during the festive season.
Under a share subscription and shareholders' agreement executed on June 26, 2026, the deal was initially expected to close within 90 working days.
The companies subsequently agreed on October 1, 2026, to extend the closing date to December 2026 before concluding the transaction
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.